drugset / Trial / NCT01612351
Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to see if a three method risk adapted design using induction chemotherapy, transoral surgery and radiation chemotherapy will lessen toxic effects and make treatment of squamous cell carcinoma of the head and neck (SCCHN) better.
Timeline
- Start
- 2012-06
- Primary completion
- 2016-11
- Completion
- 2025-05-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | — | Intravenous |
| Subject | Cisplatin | Other / unclassified | — | Intravenous |
| Subject | Lapatinib | Small molecule | 1000 mg | Oral |
| Subject | Paclitaxel | Small molecule | — | Intravenous |